All research will be carried out in the Manchester Interdisciplinary Biocentre (MIB) a unique, purpose-built, 38m facility that brings together experts from a wide range of disciplines in order to tackle major challenges in quantitative, interdisciplinary bioscience.
Professor Douglas Kell, Director of the MCISB, said: Manchester is a leading centre for Systems Biology research and it is very exciting that so many of the SysMO projects have a Manchester component. Our involvement in these projects will allow us to achieve much added value and to develop and show best practice across all of them.
Professor Hans Westerhoff, AstraZeneca Professor of Systems Biology and Director of the Doctoral Training Centre on Systems Biology at The University of Manchester, said: This is a unique opportunity to begin to understand how networking contributes to the functioning of living cells inside and outside our bodies.
It enables us to integrate the best groups from six European countries and will address four concrete issues of energy, the disease-benefit balance, white biotechnology and robustness.
Systems Biology combines molecular biology and mathematics, which have traditionally been seen as the equivalents of fire and water. This type of research is still viewed as controversial by some in the scientific community.
But researchers involved in SysMO believe this approach will allow them to obtain a very large set of mathematical equations that describe living cells. This may then allow those cells to be engineered in a number of ways, with numerous benefits in the field of medicine and in the commercial world.
|Contact: Alex Waddington|
University of Manchester